Peptides in the FDA Crosshairs | Tech News

An FDA advisory panel just voted 8 to 6 to let pharmacies legally make three popular peptides—like BPC-157 and TB-500—despite shaky science and a booming underground market. These peptides, hyped by influencers for everything from muscle recovery to gut health, currently exist in a gray zone, sold online as “research only” but often used by humans. While proponents say regulated compounding could make them safer, FDA scientists warned there’s not enough proof. Doctors shared scary stories of patients getting contaminated products. Critics fear this vote could mislead the public into thinking these substances are approved when they’re not. The final call is still pending—but this vote signals a major clash between wellness trends and science-backed safety. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/76a8409312a232ec